BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 31352525)

  • 1. Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.
    Hundemer GL
    Curr Cardiol Rep; 2019 Jul; 21(9):93. PubMed ID: 31352525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
    Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
    JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism.
    Wachtel H; Fraker DL
    Curr Cardiol Rep; 2021 Jun; 23(7):89. PubMed ID: 34081226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Aldosteronism: Practical Approach to Diagnosis and Management.
    Byrd JB; Turcu AF; Auchus RJ
    Circulation; 2018 Aug; 138(8):823-835. PubMed ID: 30359120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial Fibrillation in Primary Aldosteronism.
    Pan CT; Tsai CH; Chen ZW; Chang YY; Wu VC; Hung CS; Lin YH;
    Horm Metab Res; 2020 Jun; 52(6):357-365. PubMed ID: 32289838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and diagnosis of primary aldosteronism.
    Rossi GP
    Curr Hypertens Rep; 2010 Oct; 12(5):342-8. PubMed ID: 20665130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized Treatment of Patients With Primary Aldosteronism.
    Obeid H; Chen Cardenas SM; Khairi S; Turcu AF
    Endocr Pract; 2023 Jun; 29(6):484-490. PubMed ID: 36273684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
    Williams TA; Reincke M
    Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
    Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
    Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy.
    Adolf C; Köhler A; Franke A; Lang K; Riester A; Löw A; Heinrich DA; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Arlt W; Reincke M
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4543-4552. PubMed ID: 30113683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conn's syndrome].
    Born-Frontsberg E; Quinkler M
    Internist (Berl); 2009 Jan; 50(1):17-26. PubMed ID: 19099278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary aldosteronism: diagnostic and therapeutic considerations.
    Nishizaka MK; Calhoun DA
    Curr Cardiol Rep; 2005 Nov; 7(6):412-7. PubMed ID: 16256009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary aldosteronism: from diagnosis to therapy in clinical practice].
    Vetri M; Cassaniti L; Francese GM; Gulizia MM
    G Ital Cardiol (Rome); 2021 Apr; 22(4):319-326. PubMed ID: 33783452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.
    Morimoto S; Ichihara A
    Hypertens Res; 2020 Aug; 43(8):744-753. PubMed ID: 32424201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of drug-based and surgical treatments for primary aldosteronism.
    Steichen O; Lorthioir A; Zinzindohoue F; Plouin PF; Amar L
    Adv Chronic Kidney Dis; 2015 May; 22(3):196-203. PubMed ID: 25908468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Different Treatment Strategies on New-Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohort-Based Study.
    Pan CT; Liao CW; Tsai CH; Chen ZW; Chen L; Hung CS; Liu YC; Lin PC; Chang CC; Chang YY; Wu VC; Lin YH;
    J Am Heart Assoc; 2020 Mar; 9(5):e013699. PubMed ID: 32070205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Medical Treatment of Primary Aldosteronism.
    Li YJ; Ji ZG; Wen J
    Chin Med Sci J; 2023 Mar; 38(1):49-56. PubMed ID: 36642703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of primary hyperaldosteronism.
    Araujo-Castro M
    Med Clin (Barc); 2020 Oct; 155(7):302-308. PubMed ID: 32586668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.